Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Clinical trial NCT07510802 · RECRUITING

Trial details

NCT number: NCT07510802
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer (Advanced/Metastatic)HER2-positive Breast Cancer Triple-negative Breast Cancer

Start date: 2026-02-02
Primary completion: 2027-03-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.